Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice.

Blood
Andrew M HallS J Urbaniak

Abstract

RhD is a major blood group and the most important target antigen in hemolytic disease of the newborn (HDN). The aims of this study were to establish a humanized mouse model of responses to the RhD protein and to test whether these could be prevented by the induction of immune tolerance. HLA-DR15 is a major restricting element for human T-helper (Th) cells specific for RhD protein, and expression of this HLA-DR transgene was found to confer on mice the ability to respond to immunization with purified RhD protein. Synthetic peptides containing dominant Th cell epitopes, previously identified from studies of human alloimmunized donors, were administered to the nasal mucosa of transgenic mice before immunization with purified RhD protein. Treatment with each of the 4 dominant peptides, RhD52-66, RhD97-111, RhD117-131, and RhD177-191, inhibited T-cell priming and prevented antibody responses to the RhD protein. The ability to induce such active tolerance offers the prospect of peptide immunotherapy as a replacement for passive immune globulin in the prophylaxis of HDN.

References

Jan 21, 1988·Journal of Immunological Methods·R J SokolJ R Booth
Aug 1, 1985·Journal of Clinical Pathology·R J SokolR Stamps
May 16, 1998·European Journal of Immunology·S M Anderton, D C Wraith
Oct 16, 1999·British Journal of Haematology·M Turner
Feb 12, 2000·Journal of Immunological Methods·G DevereuxR N Barker
May 11, 2000·Blood Reviews·S J Urbaniak, M A Greiss
Dec 5, 2000·Current Opinion in Immunology·C J Elson, R N Barker
Dec 21, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·X F Bai, H Link
Mar 27, 2003·Nature Reviews. Immunology·Kathryn J Wood, Shimon Sakaguchi
Dec 3, 2003·Transfusion·John Bowman
Dec 25, 2003·Transfusion·George Garratty
Jun 24, 2004·European Journal of Immunology·Stephan EllmerichDaniel M Altmann

❮ Previous
Next ❯

Citations

May 17, 2005·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·H Ansart-PirenneF Noizat-Pirenne
Jun 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Monika KasprzyckaMariusz A Wasik
Jul 2, 2008·Obstetrics and Gynecology·Kenneth J Moise
Oct 18, 2015·Human Immunology·Zohreh Tatari-CalderoneRyad Tamouza
Nov 20, 2012·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·S DuboeufO Garraud
Jun 7, 2011·Seminars in Perinatology·Sharon Markham Geaghan
Jun 25, 2009·Vox Sanguinis·B VeldhuisenM de Haas
Oct 4, 2007·Annals of the New York Academy of Sciences·Hanna Debiec, Pierre Ronco
Jul 31, 2013·Transfusion·Elliott VichinskyUNKNOWN CDC Thalassemia Investigators
Apr 1, 2006·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·S J Urbaniak
Feb 20, 2007·American Journal of Obstetrics and Gynecology·Michael S RumaSuzanne L Lubarsky
Oct 11, 2012·Immunotherapy·Donald R Branch
Dec 24, 2013·F1000Research·André WinklerMarc Ehlers
Jul 19, 2017·Current Opinion in Hematology·Yoelys Cruz-LealAlan H Lazarus
Aug 15, 2020·British Journal of Haematology·James S CastlemanMark D Kilby
Jan 22, 2009·Médecine sciences : M/S·Pierre RoncoVincent Guigonis
Mar 7, 2021·Transfusion·Conceição Pinheiro De SouzaJosé Orlando Bordin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Blood Group Incompatibility

Blood group incompatibility between donor and recipient has been associated with poor transplant outcomes. Discover the latest research on blood group icompatibility here.